IMMU-10. INTERIM ANALYSIS OF THE HIT-HGG REZ IMMUNVAC STUDY - DENDRITIC CELL VACCINATION WITH PARTIAL TREG DEPLETION IN CHILDREN, ADOLESCENTS, AND ADULTS WITH RELAPSED HIGH-GRADE GLIOMAS

Efficacy of therapeutic dendritic cell vaccines (DCV) can be limited by immunosuppressive mechanisms in the micromilieu of high-grade gliomas. In the HIT-HGG-Rez Immunovac trial (Eudra-CT 2013-000419-26), we investigate whether a reduction of Treg with metronomic cyclophosphamide (metrCyc) might be...

Descripción completa

Detalles Bibliográficos
Autores principales: Eyrich, Matthias, Krauss, Jürgen, Rachor, Johannes, Monoranu, Camelia, Bison, Brigitte, Löhr, Mario, Rückriegel, Stefan, Wölfl, Matthias, Miller, Elisabeth, Schlegel, Paul G, Kramm, Christof
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715918/
http://dx.doi.org/10.1093/neuonc/noaa222.366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715918/
http://dx.doi.org/10.1093/neuonc/noaa222.366

Ejemplares similares